Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 1 1

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2

Conditions

Osteoporosis 2Musculoskeletal Diseases 2Hyperparathyroidism 2Humoral Hypercalcemia Of Malignancy 2Endocrine System Diseases 2Neoplasms 1Bone Diseases, Endocrine 1

Interventions

parathyroid hormone-related peptide (1-36) 2Bupivacaine 2etelcalcetide hydrochloride 1Saline Solution 1Parathyroid Hormone-Related Protein 1Parathyroid Hormone 1Dexmedetomidine 1Conscious Sedation 1Cinacalcet 1Calcitriol 1Anesthesia, General 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Hyperparathyroidism × parathyroid hormone-related peptide (1-36) × Clear all
NCT00580788 2016-02-11

One Week Parathyroid Hormone-related Protein (PTHrP) IV Dose Escalation Study

University of Pittsburgh

Phase EARLY_PHASE1 Completed
14 enrolled 16 charts
Head & Neck

Humoral Hypercalcemia Of Malignancy, Endocrine System Diseases, Hyperparathyroidism, Musculoskeletal Diseases, Neoplasms, Osteoporosis

NCT01333267 2014-12-05

One Week Comparison Study of PTH and PTHrP Infusions

University of Pittsburgh

Phase 1 Withdrawn
Head & Neck

Humoral Hypercalcemia Of Malignancy, Bone Diseases, Endocrine, Endocrine System Diseases, Hyperparathyroidism, Musculoskeletal Diseases, Osteoporosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡